Two pediatric cancers, malignant rhabdoid tumor (MRT) and Ewing sarcoma, that show sensitivity to other p53-dependent cytotoxic drugs, displayed more sensitivity to XL177A [205]. The gene discussed is TP53; the disease is cancer.